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Abstract The influence of iron status on glyceraldehyde 3-phos- 
phate dehydrogenase (GAPDH) gene transcription, mRNA levels 
and distribution was determined in whole liver samples from adult 
Wistar rats. While iron loading did not alter GAPDH expression, 
iron deficiency evoked a 2.3-fold increase in the steady-state l vel 
of liver GAPDH mRNA, but did not affect gene transcription or 
intracellular Iocalisation of the message. Therefore, the over- 
expression of GAPDH mRNA in iron deficiency is probably due 
to increased message stability. 
Key words: Glyceraldehyde 3-phosphate dehydrogenase; Iron; 
Liver; Rat; Iron-responsive element 
1. Introduction 
The cytosolic enzyme, glyceraldehyde 3-phosphate dehydro- 
genase (GAPDH),  plays a key role in glycolysis and is conse- 
quently expressed in all tissues [1]. It is composed of four iden- 
tical 37 kDa subunits, and despite the presence of over 201) 
pseudogenes, appears to be encoded by a single functional gene 
in the rat [2]. The levels of GAPDH mRNA correlate well with 
the expression of the enzyme in a variety of tissues [3]. 
GAPDH is widely used as an internal control for transcrip- 
tion and Northern analyses as it is considered to be constitu- 
tively expressed. For example, GAPDH mRNA levels are unaf- 
fected by treatment of cultured hepatocytes with cyclic AMP 
or dexamethasone [4]. Furthermore, the level of rat liver 
GAPDH mRNA correlates well with that of ribosomal RNA 
during development [5]. However, insulin markedly increases 
GAPDH mRNA in 3T3-F442A adipocytes and H35 hepatoma 
cell lines [6]. Murine T-lymphocytes respond to interleukin-2 by 
exhibiting a 2- to 5- fold increase in GAPDH mRNA,  in part 
due to increased gene transcription [7]. Furthermore, triiodo- 
thyronine (T3) administration of hypophysectomised rats re- 
sults in a 20-fold increase in liver GAPDH mRNA expression 
[8]. Thus GAPDH is not constitutively expressed in several 
instances in specific cell types. 
Iron is required by all vertebrate cells. Varying iron levels 
leads to changes in the expression of proteins actively involved 
in its metabolism. Differing iron status or concentration can 
affect ferritin [9], transferrin [10] and transferrin receptor [11] 
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expression. The present study indicates that GAPDH mRNA 
levels are also influenced by iron status. In the Wistar rat, iron 
deficiency evoked a 2.3-fold increase in liver mRNA,  without 
altering GAPDH gene transcription or mRNA polysomal dis- 
tribution profile, indicating that post-transcriptional mecha- 
nisms, possibly stabilisation of mRNA are responsible. 
2. Materials and methods 
2.1. Animals 
Male Wistar rats were used in these xperiments. Iron deficiency was 
produced by feeding a low-iron diet, based on that used by Diplock et 
al. [12], containing 5 10 mg of iron per kg. Controls for the iron 
deficient rats were fed the same low-iron diet supplemented with 1.3 
g/kg ferrous ammonium sulphate. Iron excess was achieved by feeding 
a normal chow diet with 1.5% carbonyl iron (Ferronyl, GAF Corp.) 
added. Controls for these animals were maintained on normal chow 
(Milne Feeds Ltd., Perth, Australia). All diets were commenced during 
pregnancy (day 12-15) and continued for male offspring postnatally. 
As both sets of 'control' animals were found to be identical with regard 
to iron status and all of the parameters determined, these rats will be 
referred to as controls, with the results being presented concomitantly. 
The animals on the low and high iron diets will be referred to as iron 
deficient and iron overload rats, respectively. 
At 6 weeks of age the rats were anaesthetised using ether. Blood (3 
ml) was obtained by heart puncture and collected in heparinised tubes 
and plasma isolated via centrifugation. The animals were then sacri- 
ficed by cervical dislocation and the brains and livers removed and 
placed on ice. 
2.2. Analytical methods 
Iron status was evaluated by measuring liver and brain non-haem 
iron [13], plasma iron concentration [14] and packed cell volume (PCV) 
by the microhaematocrit method. Plasma glucose levels were measured 
on a Beckman Glucose Analyser. 
2.3, RNA Isolation and mRNA detection 
Total RNA was isolated from whole liver and brain by lithium 
chloride/urea extraction [15]. Samples of RNA (20 ~ug) were electro- 
phoresed in a 1.0% agarose gel containing 2.2 M formaldehyde [16] and 
transferred onto Hybond-N membranes (Amersham) by capillary blot. 
GAPDH mRNA was detected by hybridisation with pRGAPDH-13 
cDNA [17] and RNA loading assessed by hybridisation to an 18S 
rRNA probe [18]. Both cDNAs were labelled with [c~-3Zp]dCTP (Amer- 
sham) using an Amersham Nick translation kit and hybridised at 42°C 
for 24 h. The hybridised membranes were washed according to the 
manufacturer's in tructions and exposed to Fuji RX-OH film at -70 ° C, 
with a GI 2 intensifying screen. Quantitative analysis was performed by 
scanning the film using a document scanner fitted with a transparency 
attachment (UMAX, UC630), and then analysing the digitised image 
using NIH Image (National Institute of Health, USA). 
2.4. Fractionation of liver RNA 
Polysome gradients were prepared from cytoplasmic extracts of 
whole liver samples on a 10 50% sucrose gradient [19]. RNA was 
prepared from the resultant 2 ml fractions by first precipitating with 
sodium acetate/ethanol, f llowed by RNA purification using a modifi- 
cation of the method of LeMeur [15]. Northern analysis of 20 /dg 
samples from each fraction was performed, as above. 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)00023-2 
E.A. Quail, G.CZ YeohlFEBS Letters 359 (1995) 126-128 127 
2.5. Transcription assay 
'Run-on' transcription assays of isolated liver nuclei were performed 
as described by Shelly et al. [20], using cDNA for GAPDH [17], rat 
albumin [21] and pGEM 3zf(+) (Promega) as a negative control. Re- 
sults are expressed as transcription of GAPDH gene relative to albu- 
min. 
3. Results and discussion 
As shown in Table 1, iron-deficient and iron-overloaded an- 
imals differed from control rats with respect to PCV; whole 
body, liver and brain weights; and liver, brain and plasma iron 
concentrations. As GAPDH plays a key role in gluconeogenesis 
(formation of NADH from NAD +) plasma glucose levels were 
determined to ensure that any changes in GAPDH liver mRNA 
was not a response to differences in sugar content of the various 
diets. The consistent plasma glucose levels observed (Table 1) 
indicate that this was not the case. Previous work demonstrated 
that dietary protein depletion of mice causes an accumulation 
in liver cytosolic GAPDH protein, associated with increased 
synthesis [22]. However, as both sets of 'control' animals were 
identical with respect o all determined parameters, it is unlikely 
that dietary differences (other than iron loading) influenced 
GAPDH expression in these studies. 
The effect of iron status on GAPDH mRNA was determined 
by Northern analysis. A single mRNA species of 1.27 kb was 
detected in both brain and liver samples (Fig. la). Iron deficient 
rats displayed a 2.3-fold increase in liver GAPDH mRNA rel- 
ative to 18S rRNA transcripts, when compared with the control 
rats (Fig. lb); while no change in brain GAPDH mRNA was 
seen with varying iron status. 
The increase in liver mRNA was further investigated by 
'run-on' transcription assay and determination of  relative 
mRNA distribution between free and bound polysomes. The 
level of GAPDH gene transcription remained constant, relative 
to albumin, for the three groups of rats (results not shown). 
Therefore it could not account for the increase in liver GAPDH 
mRNA levels. Furthermore, no change in the polyribosomal 
distribution of the GAPDH mRNA was observed with varying 
iron status (Fig. 2a). The distribution of L-ferritin mRNA was 
shown to vary with iron status (Fig. 2b), as previously reported 
[19]. 
Therefore, the over-expression f GAPDH mRNA is due to 
a post-transcriptional effect of iron depletion on the liver 
mRNA and is likely to be related to an increase in message 
stability. The enhanced stability of transferrin receptor mRNA 
in iron depletion has been shown to be mediated by specific 
Table 1 
Indices of iron status in iron-deficient, control and iron-overload rats 
Parameters Iron-deficient Control Iron-overload 
PCV (%) 15.2 _+ 0.9 38.5 + 1.1 38.8 + 1.5 
Body weight (g) 104.3 + 3.8 116.8 + 3.6 41.1 + 1.3 
Liver weight (g) 3.70 + 0.3 5.21 + 0.4 2.19 + 0.1 
Brain weight (g) 1.55 + 0.04 1.65 _+ 0.02 1.28 + 0.27 
Liver iron (,ug/g) 9.5 - 0.6 51.0 + 2.9 1761 _+ 42.7 
Brain iron (~g/g) 5.8 + 0.44 8.6 + 0.32 9.1 + 0.63 
Plasma iron (/tg/ml) 0.45 + 0.06 2.36 + 0.2 4.24 _+ 0.16 
Plasma glucose (mM) 7.1 + 0.37 7.5 _+ 0.32 7.0 + 0.31 
Comparison of PCV; body, liver and brain weights; liver, brain and 
plasma iron concentrations and plasma glucose concentrations in iron- 
deficient, control and iron-overload rats. Results are mean + S.E.M. of 
six animals in each case, in total twelve for the 'control' animals. 
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Fig. I. (a) Northern blot analysis of 20 pg samples of whole liver and 
brain RNA isolated from six individual iron deficient ([]), control (ez~) 
and iron overload (m) rats. Autoradiographs (a) of Northern mem- 
branes probed with cDNAs for GAPDH and 18SrRNA, and histo- 
grams (b), results are expressed as GAPDH mRNA relative to mRNA 
for 18 S rRNA and are the mean + S.E.M. of six samples in each case. 
3 ' -UTR iron-responsive elements (IRE) [23]. Other mRNAs,  
for example ferritin [24], also contain IREs. A Genbank search 
of the published GAPDH sequences failed to detect any con- 
sensus IREs; however, it is possible that an as yet unrecognised 
iron-responsive sequence may control GAPDH expression by 
iron. 
Liver GAPDH mRNA levels increase in hypophysectomised 
rats 20-fold upon T 3 administration [8], and iron deficiency 
causes a fall in plasma T 3 concentration [26,26]. Thus it would 
be anticipated that iron deficiency would result in decreased 
liver GAPDH mRNA levels. However, the results of this study 
show that this is not the case as iron deficiency increased liver 
GAPDH mRNA.  Furthermore, plasma glucose concentrations 
did not differ with iron status or diet. Thus it appears that there 
are at least two types of control of GAPDH liver mRNA levels. 
One involves thyroid hormones, and the second iron. The inter- 
relationship between these is unclear. In summary, this work 
demonstrates that the expression of GAPDH mRNA is influ- 
enced by iron levels and therefore it is not a suitable reference 
under conditions of altered iron status. 
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Fig. 2. Polysomal distribution of rat liver mRNA for (a) GAPDH and 
(b) L-ferritin, determined by Northern blot analysis of 20/.zg samples 
of fractionated RNA isolated from iron-deficient (A), control (o) and 
iron-overload (A) rats. Results are expressed as percentage of the total 
mRNA in individual fractions and are the mean values for two North- 
erns in each case. 
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